These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

108 related articles for article (PubMed ID: 2488435)

  • 21. Severe sulfadiazine hypersensitivity in a child with reactivated congenital toxoplasmic chorioretinitis.
    McLeod R; Khan AR; Noble GA; Latkany P; Jalbrzikowski J; Boyer K;
    Pediatr Infect Dis J; 2006 Mar; 25(3):270-2. PubMed ID: 16511396
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Longitudinal study of new eye lesions in treated congenital toxoplasmosis.
    Phan L; Kasza K; Jalbrzikowski J; Noble AG; Latkany P; Kuo A; Mieler W; Meyers S; Rabiah P; Boyer K; Swisher C; Mets M; Roizen N; Cezar S; Remington J; Meier P; McLeod R;
    Ophthalmology; 2008 Mar; 115(3):553-559.e8. PubMed ID: 17825418
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Treatment of recurrent congenital ocular toxoplasmosis. Our initial experience with Fansidar].
    Comte P; Verin P; Le Bras M
    Bull Soc Ophtalmol Fr; 1989 Apr; 89(4):567-8, 571-2. PubMed ID: 2686844
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Prospective randomized trial of trimethoprim/sulfamethoxazole versus pyrimethamine and sulfadiazine in the treatment of ocular toxoplasmosis.
    Soheilian M; Sadoughi MM; Ghajarnia M; Dehghan MH; Yazdani S; Behboudi H; Anisian A; Peyman GA
    Ophthalmology; 2005 Nov; 112(11):1876-82. PubMed ID: 16171866
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Segmental retinal arteritis and retinochorioiditis].
    Tetz M; Holz FG; Gallasch G; Völcker HE
    Ophthalmologe; 1992 Feb; 89(1):71-6. PubMed ID: 1581697
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [An analysis of the treatment and evolution of 56 cases of ocular toxoplasmosis].
    Atías A; Pasmanik S; Niedmann G
    Bol Chil Parasitol; 1966; 21(4):108-11. PubMed ID: 5990162
    [No Abstract]   [Full Text] [Related]  

  • 27. [Results of therapy in ocular toxoplasmosis. Comparison of various forms of therapy].
    Damms T; Böhnke M; Behrend-Berdin B
    Ophthalmologe; 1993 Dec; 90(6):737-41. PubMed ID: 8124045
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Toxoplasmosis. III. Ocular diseases and therapy].
    Marcinkowski K
    Klin Oczna; 1976 Jun; 46(6):691-4. PubMed ID: 966630
    [No Abstract]   [Full Text] [Related]  

  • 29. The treatment of toxoplasmic posterior uveitis (chorioretinitis).
    Giles CL
    Am J Med Sci; 1966 Feb; 251(2):241-2. PubMed ID: 5295371
    [No Abstract]   [Full Text] [Related]  

  • 30. Recurrent secondary frosted branch angiitis after toxoplasmosis vasculitis.
    Oh J; Huh K; Kim SW
    Acta Ophthalmol Scand; 2005 Feb; 83(1):115-7. PubMed ID: 15715571
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Extensive toxoplasmic retinochoroiditis. Diagnostic and therapeutic management].
    Theaudin M; Bodaghi B; Cassoux N; Romand S; Le Mer Y; Lemaitre C; Fardeau C; Thulliez P; LeHoang P
    J Fr Ophtalmol; 2003 Nov; 26(9):921-7. PubMed ID: 14631276
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Short-term effects of the clindamycin-steroid regimen in the treatment of ocular toxoplasmosis.
    Djurkovic-Djakovic O; Stanojevic-Paovic A; Bobic B; Bergam J; Nikolic A; Paovic J; Vukovic D
    J Chemother; 1995 Nov; 7 Suppl 4():199-201. PubMed ID: 8904155
    [No Abstract]   [Full Text] [Related]  

  • 33. [Clinical view of toxoplasmosis in children--personal observations].
    Czarnecka-Rudnik D; Stanek-Bazylko F
    Pol Merkur Lekarski; 1997 May; 2(11):327-30. PubMed ID: 9377683
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Postnatal ocular toxoplasmosis in a grown woman].
    Bowles EC; Hillenius JM; Biesma DH; Kortbeek LM; de Jongh BM
    Ned Tijdschr Geneeskd; 2009 Feb; 153(7):292-6. PubMed ID: 19291946
    [No Abstract]   [Full Text] [Related]  

  • 35. [Sulfadiazine, pyrimethamine, spiramycin and folic acid in congenital toxoplasmosis].
    Sedan J
    Mars Med; 1967; 104(4):343-5. PubMed ID: 5621539
    [No Abstract]   [Full Text] [Related]  

  • 36. Outcome of treatment for congenital toxoplasmosis, 1981-2004: the National Collaborative Chicago-Based, Congenital Toxoplasmosis Study.
    McLeod R; Boyer K; Karrison T; Kasza K; Swisher C; Roizen N; Jalbrzikowski J; Remington J; Heydemann P; Noble AG; Mets M; Holfels E; Withers S; Latkany P; Meier P;
    Clin Infect Dis; 2006 May; 42(10):1383-94. PubMed ID: 16619149
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Prophylactic treatment of recurrent attacks of uveitis due to I. toxoplasmosis and 2. streptococci.
    Linton RG
    Trans Aust Coll Ophthalmol; 1969; 1():88-9. PubMed ID: 5400536
    [No Abstract]   [Full Text] [Related]  

  • 38. [Value of clindamycin in the treatment of ocular toxoplasmosis].
    Jeddi A; Azaiez A; Bouguila H; Kaoueche M; Malouche S; Daghfous F; Ayed S
    J Fr Ophtalmol; 1997; 20(6):418-22. PubMed ID: 9296037
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Serological reactions in ocular toxoplasmosis prior to and following Daraprim treatment].
    Zemburowa K; Ziobrowski S; Laskownicka Z; Barbarowski H; Mossakowska J
    Wiad Parazytol; 1972; 18(2):213-6. PubMed ID: 5086459
    [No Abstract]   [Full Text] [Related]  

  • 40. [Influence of the treatment on humoral immunity in toxoplasmosis].
    Durquety MC; Verin P; Le Rebeller MJ
    Bull Soc Ophtalmol Fr; 1984 Oct; 84(10):1089-93, 1096. PubMed ID: 6544162
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.